Anti-GUC2C/ GUCY2C/ DIAR6 monoclonal antibody

Anti-GUC2C/ GUCY2C/ DIAR6 antibody for FACS & in-vivo assay

Target products collectionGo to GUCY2C/GUCY2C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T97947-Ab-1/ GM-Tg-hg-T97947-Ab-2Anti-Human GUCY2C monoclonal antibodyHuman
GM-Tg-rg-T97947-Ab-1/ GM-Tg-rg-T97947-Ab-2Anti-Rat GUCY2C monoclonal antibodyRat
GM-Tg-mg-T97947-Ab-1/ GM-Tg-mg-T97947-Ab-2Anti-Mouse GUCY2C monoclonal antibodyMouse
GM-Tg-cynog-T97947-Ab-1/ GM-Tg-cynog-T97947-Ab-2Anti-Cynomolgus/ Rhesus macaque GUCY2C monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T97947-Ab-1/ GM-Tg-felg-T97947-Ab-2Anti-Feline GUCY2C monoclonal antibodyFeline
GM-Tg-cang-T97947-Ab-1/ GM-Tg-cang-T97947-Ab-2Anti-Canine GUCY2C monoclonal antibodyCanine
GM-Tg-bovg-T97947-Ab-1/ GM-Tg-bovg-T97947-Ab-2Anti-Bovine GUCY2C monoclonal antibodyBovine
GM-Tg-equg-T97947-Ab-1/ GM-Tg-equg-T97947-Ab-2Anti-Equine GUCY2C monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T97947-Ab-1/ GM-Tg-hg-T97947-Ab-2; GM-Tg-rg-T97947-Ab-1/ GM-Tg-rg-T97947-Ab-2;
GM-Tg-mg-T97947-Ab-1/ GM-Tg-mg-T97947-Ab-2; GM-Tg-cynog-T97947-Ab-1/ GM-Tg-cynog-T97947-Ab-2;
GM-Tg-felg-T97947-Ab-1/ GM-Tg-felg-T97947-Ab-2; GM-Tg-cang-T97947-Ab-1/ GM-Tg-cang-T97947-Ab-2;
GM-Tg-bovg-T97947-Ab-1/ GM-Tg-bovg-T97947-Ab-2; GM-Tg-equg-T97947-Ab-1/ GM-Tg-equg-T97947-Ab-2
Products NameAnti-GUCY2C monoclonal antibody
Formatmab
Target NameGUCY2C
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GUCY2C benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-272Pre-Made Indusatumab biosimilar, Whole mAb ADC, Anti-GUCY2C Antibody: Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic antibody
    BiosimilarGMP-Bios-INN-866Pre-Made Indusatumab Vedotin Biosimilar, Whole Mab Adc, Anti-Gucy2C Antibody: Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic antibody Drug Conjugate
    Target AntigenProducts DevelopingMulti-species GUC2C/ GUCY2C/ DIAR6 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T97947
    Target NameGUCY2C
    Gene ID2984,14917,25711,699191,486671,101095109,282244,100063810
    Gene Symbol and SynonymsDIAR6,GC-C,GCC,GUC2C,GUCY2C,HSER,MECIL,MUCIL,STAR
    Uniprot AccessionP25092,P23897
    Uniprot Entry NameGUC2C_HUMAN,GUC2C_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index
    DiseaseN/A
    Gene EnsemblENSG00000070019
    Target ClassificationCheckpoint-Immuno Oncology

    The target: GUCY2C, gene name: GUCY2C, also named as DIAR6, GC-C, GUC2C, MECIL, MUCIL, STAR. This gene encodes a transmembrane protein that functions as a receptor for endogenous peptides guanylin and uroguanylin, and the heat-stable E. coli enterotoxin. The encoded protein activates the cystic fibrosis transmembrane conductance regulator. Mutations in this gene are associated with familial diarrhea (autosomal dominant) and meconium ileus (autosomal recessive). [provided by RefSeq, Nov 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.